Vaxart, Inc.

VXRT

39 Followers
$0.42 +3.10% $0.01
12 May
Upcoming Earnings
 
Market Cap.
 
P/E
Loading...

My Notes

Začít psát

Profile

Vaxart, Inc. (VXRT) is an American biotechnology company specializing in vaccine research and development. The company focuses on an innovative adenovirus-based vaccine platform, which enables the creation of vaccines against various infectious diseases. Vaxart works on vaccines targeting viral infections, including influenza, respiratory viral diseases, and other infections. With its technological approach and research capabilities, Vaxart aims to bring new possibilities in the field of vaccination and treatment of infectious diseases. Vaxart, Inc. (VXRT) shares are an attractive choice for investors following the biotechnology sector and seeking investment opportunities in vaccines and viral disease treatments.

Feed

Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade